• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Xceleron (Chapter 11)

edit

Xceleron Ltd entered administration (chapter 11) on January 10th 2012 with debts of £7m. It provided bioanalytical accelerator mass spectrometry (AMS) services for drug development. It conducted microdosing, pre-clinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. The company served the pharmaceutical and biotechnology markets. Xceleron Ltd was formerly known as The Centre for Biomedical Accelerator Mass Spectrometry Ltd. and changed its name to Xceleron Ltd in 2003. The company was founded in 1997 and was headquartered in York, the United Kingdom with a facility in Maryland.

Recent Milestones

edit

• 
  Xceleron (Chapter 11) — Insolvent and entered administration on January 10th. (4/23/12)
  Posted 4/18/12 at 8:39am via gov.uk
• 
  Xceleron (Chapter 11) received $2.4M in Venture Round funding. (2/6/12)
  Posted 2/6/12 at 6:56pm via finsmes.com
• 
  Xceleron (Chapter 11) received () in Venture Round funding. (1/20/10)
  Posted 1/22/10 at 12:47am via dowjones.com
• 
  Xceleron (Chapter 11) added Michael J. Butler as CEO & Board Of director. (12/1/08)
  Posted 1/22/10 at 12:47am
• 
  Xceleron (Chapter 11) received $3.65M (£2M) in Venture Round funding. (5/25/05)
  Posted 7/4/10 at 11:38pm via ac.uk

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/22/10

Sources

1. Spin-out backing strengthens University of York business links (york.ac.uk) [edit]
2. Xceleron Looks To Accelerate Drug Research With Fresh Funds (fis.dowjones.com) [edit]
3. Xceleron Raises $2.4M in Funding (finsmes.com) [edit]
Companies House (wck2.companieshouse.gov.uk) [edit]